Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: Outcomes after 7 years' experience of a new centre for peritoneal surface malignancies

Clinical and Translational Oncology

Volumn 12, Issue 6, 2010, Pages 437-442

  Bretcha Boix, Pedro ^a   Farré Alegre, Jose ^a   Sureda, Manuel ^a   Dussan, Carlos ^a   Ruixo, Juan José Pérez ^a   Masllorens, Antonio Brugarolas ^a  

^a USP Hospital San Jaime   (Spain)

Author keywords

Colorectal cancer; HIPEC; Intraoperative chemotherapy; Intraperitoneal chemotherapy; Peritoneal carcinomatosis; Peritoneal perfusion; Peritoneal surface malignancy

Indexed keywords

FLUOROURACIL; MITOMYCIN C; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANASTOMOSIS DEHISCENCE; ARTICLE; BILE DUCT FISTULA; BONE MARROW APLASIA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DOSE ESCALATION; DRUG SAFETY; EARLY INTERVENTION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEMOPERITONEUM; HUMAN; HYPERTHERMIC THERAPY; INTESTINE FISTULA; LENGTH OF STAY; LIVER METASTASIS; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PHASE 1 CLINICAL TRIAL; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; SALVAGE THERAPY; SEPSIS; SUBPHRENIC ABSCESS; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT DURATION; TREATMENT PLANNING; WORK EXPERIENCE; ADJUVANT CHEMOTHERAPY; CARCINOMA; COLONIC NEOPLASMS; COLORECTAL SURGERY; DRUG ADMINISTRATION; EVALUATION STUDY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEAL NEOPLASMS; PERITONEUM; PROCEDURES; RETROSPECTIVE STUDY; SECONDARY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COLORECTAL SURGERY; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PERITONEUM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77955959325     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-010-0531-7     Document Type: Article

References (36)

1. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fl uorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
2. Hurwitz HI, Fehrenbacher L, Hainsworth JD et al (2005) Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23:3502-3508
3. Kabbinavar FF, Schulz J, McCleod M et al (2005) Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23:3697-3705
4. Sugarbaker PH (1998) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14:254-261
5. Takahashi I, Emi Y, Hasuda S et al (2002) Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors.Surgery 131:S78-S84
6. Verwall V, van Ruth S, de Bree E et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.J Clin Oncol 21:3737-3743
7. Begossi G, Gonzalez Moreno S, Ortega Perez G et al (2002) Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.EJSO 28:80-87
8. González Moreno S (2006) Fourth International Workshop on Peritoneal Surface Malignancy: summary, conclusions and consensus. Eur J Surg Oncol 32(6):593-596
9. Esquivel J, Sticca R, Sugarbaker PH et al (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14(1):128-133
10. Sugarbaker PH (1995) Peritonectomy procedures.Ann Surg 221:29-42
11. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359-374
12. Sugarbaker P, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124-132
13. Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727-731
14. Elias D, Bonnay M, Puizillou J et al (2002) Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 13:267-272
15. Elias D, Sideris L, Pocard M et al (2004) Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 15:781-785
16. Sadeghi B, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: Results from the EVOCAPE 1 multicentric prospective study. Cancer 88:358-363
17. Witkamp A, de Bree E, Van Goethem, Zoetmulder F (2001) Rationale and techniques of intraoperative hyperthermic intraperitoneal chemotherapy.Cancer Treat Rev 27:365-374
18. Glehen O, Mithieux F, Osinsky D et al (2003) Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 21(5):799-806
19. Witkamp A, de Bree E, Kaag M et al (2001) Extensive cytoreductive surgery followed by intraoperative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979-984
20. Carmingnani C, Esquivel J, Sugarbaker PH (2003) Cytoreductive surgery and intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. Rev Oncol 5(4):192-198
21. Shen P, Levine E, Hall J et al (2003) Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.Arch of Surg 138(1):26-33
22. Jayne D, Fook S, Loi C, Seow-Choen F (2002) Peritoneal carcinomatosis from colorectal cancer.Br J Surg 89(12):1545-1550
23. Elias D, Lefevre JH, Chevalier J et al (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681-685
24. Glehen O, Kwiatkowski F, Sugarbaker PH et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284-3292
25. Verwaal V, van Ruth S, de Bree E et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.J Clin Oncol 21:3737-3743
26. Verwaal V, van Ruth S, Witkamp A et al (2005) Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 12(1):65-71
27. Elias D, Raynard B, Farkhondeh F et al (2006) Peritoneal carcinomatosis of colorectal origin.Gastroenterol Clin Biol 30(10):1200-1204
28. Elias D, Benizri E, Di Pietrantonio D et al (2007) Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 14(2):509-514
29. Sugarbaker PH, Mora JT; Carmignani P et al (2005) Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 10:112-122
30. Yan T, Sugarbaker PH (2007) An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis. Ann Surg Oncol 14(7):2171-2172
31. Glehen O, Osinsky D, Cotte E et al (2003) Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863-869
32. Elias D, Goere D, Blot F et al (2007) Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 14(6):1818-1824
33. Shen P, Hawksworth J, Lovato J et al (2004) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11:178-186
34. da Silva RG, Sugarbaker PH (2006) Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203(6):878-886
35. Gertsch P (2003) A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments. Surg Oncol Clin North Am 12:531-541
36. Bartlett D (2008) HIPEC: the complexities of clinical trials. Ann Surg Oncol 15(5):1277-1279